+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
All Genders
ID06633276

Evaluating Nanopore Sequencing for Faster Breast Cancer Diagnosis in Tanzania A Prospective Observational Study

Led by University of Bonn · Updated on 2026-10-16

100

Participants Needed

1

Research Sites

30 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the use of nanopore sequencing as a method for diagnosing breast cancer in Tanzania, aiming to determine if it is as effective as the current standard of care. This study focuses on patients with suspected breast cancer and explores whether this new sequencing technology can provide faster and more cost-efficient diagnosis, which could improve treatment planning and outcomes, especially in resource-limited settings. Patients with suspected breast cancer undergoing biopsy or surgical resection will have excess fresh tissue samples tested using nanopore sequencing alongside the standard methods, which include histopathology and biomarker analysis for estrogen receptor, progesterone receptor, and HER2 status. The study investigates low-pass whole genome sequencing and DNA methylation-based classification to identify invasive ductal breast cancer and its subtypes. The goal is to provide results within hours in a point-of-care setting without changing patient treatment based on the new sequencing results. Participants will have their excess tissue preserved for DNA extraction and analysis. Researchers will measure how well nanopore sequencing matches the current standard, its feasibility, and the time it takes to deliver results. Patient quality of life and experiences during their healthcare journey will also be assessed at various timepoints. The study is expected to last about one year from the start of enrollment, with final evaluations after completion.

CONDITIONS

Brief Title

Fast and Accurate Breast Cancer Diagnosis Using Nanopore Sequencing in Tanzania (Fast-ABCD Sequencing)

Research Team

O

Oliver Henke, MD

M

Maximilian Rost, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here